Antiverse

Designing antibodies for the most challenging targets

Cardiff, United States · Founded 2020 · $13.9M raised

Headquarters
Cardiff
Employees
11–50
Founded
2020
Business Model
B2B
Total Funding
$13.9M
Last Round
$9.3M Series AMar 2026
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Antiverse is a Cardiff, Wales-based techbio company that uses generative AI and advanced cell line engineering to design therapeutic antibodies against challenging drug targets, including G-protein coupled receptors and ion channels.

Summary

Antiverse is a Biotech company based in Cardiff, United States, founded in 2020. It has raised $13.9M in total across 2 rounds, most recently a $9.3M Series A round in Mar 2026. Investors include i&i Biotech Fund and Kadmos Capital.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AMar 2026
$9.3M

Sign up to see all 2 events

Funding: Seed through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Antiverse on Indexed.vc
<a href="https://indexed.vc/companies/antiverse"><img src="https://indexed.vc/api/badge/company/antiverse" alt="Antiverse on Indexed.vc" width="260" height="76" /></a>